Neurocrine
+$2.27 (+2.53%) As of 4:30 PM UTC today
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Neurocrine and other ETFs, options, and stocks.
About NBIX
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company. It discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders.
CEO
Kevin Charles Gorman
Employees
900
Headquarters
San Diego, California
Founded
1992
NBIX Key Statistics
Market cap
8.80B
Price-Earnings ratio
123.27
Dividend yield
—
Average volume
616.31K
High today
$92.24
Low today
$88.23
Open price
$88.23
Volume
287.64K
52 Week high
$108.02
52 Week low
$71.88
Analyst ratings
62%
of 26 ratings
Buy
61.5%
Hold
34.6%
Sell
3.8%
NBIX Earnings
$0.00
$0.32
$0.65
$0.97
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 3, Pre-Market